These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16458121)

  • 21. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells.
    Chen T; Deng C
    Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake.
    Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
    Int J Oncol; 2007 Mar; 30(3):695-700. PubMed ID: 17273771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
    Kunze D; Wuttig D; Fuessel S; Kraemer K; Kotzsch M; Meye A; Grimm MO; Hakenberg OW; Wirth MP
    Anticancer Res; 2008; 28(4B):2259-63. PubMed ID: 18751404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway.
    Croci DO; Cogno IS; Vittar NB; Salvatierra E; Trajtenberg F; Podhajcer OL; Osinaga E; Rabinovich GA; Rivarola VA
    J Cell Biochem; 2008 Oct; 105(2):381-90. PubMed ID: 18553460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity and apoptosis by survivin small interfering RNA in bladder cancer cells.
    Ku JH; Seo SY; Kwak C; Kim HH
    BJU Int; 2010 Dec; 106(11):1812-6. PubMed ID: 20201832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism between a siRNA targeted to survivin and 5-FU in inhibiting MCF-7 cell proliferation in vitro.
    Zhang SQ; Zhang SH; Xue XH; Wang XJ; Jiang JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):251-4. PubMed ID: 16546719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
    Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
    Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Yoo J; Lee YJ
    Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short hairpin RNA targeting survivin inhibits growth and angiogenesis of glioma U251 cells.
    Zhen HN; Li LW; Zhang W; Fei Z; Shi CH; Yang TT; Bai WT; Zhang X
    Int J Oncol; 2007 Nov; 31(5):1111-7. PubMed ID: 17912437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
    Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells.
    Hideshima T; Catley L; Raje N; Chauhan D; Podar K; Mitsiades C; Tai YT; Vallet S; Kiziltepe T; Ocio E; Ikeda H; Okawa Y; Hideshima H; Munshi NC; Yasui H; Richardson PG; Anderson KC
    Br J Haematol; 2007 Sep; 138(6):783-91. PubMed ID: 17760810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model.
    Tian B; Wang Z; Zhao Y; Wang D; Li Y; Ma L; Li X; Li J; Xiao N; Tian J; Rodriguez R
    Cancer Lett; 2008 Jun; 264(2):299-308. PubMed ID: 18342436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced sensitivity to mitomycin C by abating heat shock protein 70 expression in human bladder cancer cell line of BIU-87.
    He LF; Guan KP; Yan Z; Ye HY; Xu KX; Ren L; Hou SK
    Chin Med J (Engl); 2005 Dec; 118(23):1965-72. PubMed ID: 16336832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA; Nikitakis NG; Sauk JJ
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
    Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
    Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. siRNA-mediated inhibition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells.
    Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
    Anticancer Res; 2012 Oct; 32(10):4313-8. PubMed ID: 23060552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
    Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
    Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.